New nanoparticle could improve cancer detection, drug delivery

Feb 12, 2010

( -- University of Florida scientists have developed a new nanoparticle that could improve cancer detection and drug delivery. The particle, called a 'micelle' and made up of a cluster of molecules called aptamers, easily recognizes tumors and binds strongly to them. It also has properties that allow it to easily get inside cells for intracellular studies and drug delivery.

“That is important, because we could attach a drug to the aptamer so that the drug could get into a cell,” said Yanrong Wu, who recently completed her doctoral research at UF. Wu was the first author of a paper describing the findings in January in the .

In allowing more targeted treatment of diseased cells, the micelles would help reduce damage to healthy cells even with large doses of chemotherapy. Current methods often destroy normal cells while trying to kill .

In biological studies, molecules termed “probes” have properties that enable them to detect other molecules or organisms of interest, such as viruses. Compared with existing probes such as antibodies, the aptamers offer advantages in terms of ease of production and identification, faster response time and much lower molecular weight.

Aptamers, the building blocks of the micelles, are short single strands of DNA that can recognize other molecules based on certain chemical conformation.

In previous drug delivery tests, aptamers on their own could only attach limited and sometimes could not effectively recognize tumor cells, so UF researchers re-engineered the molecule to improve its usefulness in biomedical studies in the watery environment inside the body.

They effectively turned the aptamer molecules into a molecular recognition and combination that escorts water-insoluble compounds such as drugs into cells by encapsulating them inside a water-soluble structure.

To do so, the team, led by Weihong Tan, the V.T. and Louise Jackson professor of chemistry at the College of Liberal Arts and Sciences and a professor of physiology and functional genomics in the UF College of Medicine, attached a “water-hating” — or hydrophobic — tail to the aptamers. The new molecules cluster together to form a micelle by tucking their water-hating tails together, exposing only the “water-loving” — or hydrophilic — portion of the structure. In that way, the micelle can shield water-insoluble agents such as drugs within its center, and help usher them into cells.

“It was kind of a stealth situation where the cell sees only the hydrophilic part, but inside, the drug is in the hydrophobic part,” said Nick Turro, the William P. Schweitzer professor of chemistry at Columbia University, who was not involved in the study. “This opens a number of avenues that were unavailable before.”

In tests that mimic physiological conditions, the micelles were more sensitive than the molecular probes alone. The micelle bound more strongly to target cells. That could lead to easier and earlier detection of biomarkers of disease such as cancer.

“When you are talking about diagnosis, these aptamers in micelles will have a much higher signal than individual aptamers, so we may be able to detect very small amounts of the substance we’re testing for,” said Tan, also a member of the UF Genetics Institute, the UF Shands Cancer Center and the Moffitt Cancer Center and Research Institute.

The micelle structures also might prove useful to more accurately determine how much diseased tissue is left behind after chemotherapy or surgery.

Now that the researchers have demonstrated the micelle’s ability to bind in simulated physiological conditions, the next step will be to test it in real tumors.

Explore further: Scientists convert microbubbles to nanoparticles

Related Stories

Molecular detectors may refine cancer treatment

Jul 19, 2007

University of Florida researchers have successfully used molecular probes to detect subtle differences in leukemia cells from patient samples, an achievement that could lead to more effective ways to diagnose and treat cancer.

New Cancer Drug Delivery System Is Effective and Reversible

Aug 31, 2009

For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug also must spare healthy cells, and ideally its effects will be reversible to cut short any potentially dangerous side ...

Scientists closer to new cancer detection method

Nov 29, 2005

University of Florida researchers say they are a step closer to a technique to easily detect a wide variety of cancers before symptoms become apparent. The findings, currently online in the Proceedings of the National Ac ...

Recommended for you

Scientists convert microbubbles to nanoparticles

Mar 30, 2015

Biomedical researchers led by Dr. Gang Zheng at Princess Margaret Cancer Centre have successfully converted microbubble technology already used in diagnostic imaging into nanoparticles that stay trapped in tumours to potentially ...

Designer's toolkit for dynamic DNA nanomachines

Mar 26, 2015

The latest DNA nanodevices created at the Technische Universitaet Muenchen (TUM)—including a robot with movable arms, a book that opens and closes, a switchable gear, and an actuator—may be intriguing ...

Simple method of binding pollutants in water

Mar 26, 2015

New types of membrane adsorbers remove unwanted particles from water and also, at the same time, dissolved substances such as the hormonally active bis-phenol A or toxic lead. To do this, researchers at the ...

Gold nanoparticles for targeted cancer treatment

Mar 26, 2015

The use of tiny drug-loaded nanocarriers for the safe, targeted delivery of drugs to designated parts of the body has received much press in recent years. Human trials of nanocarriers targeting pancreatic ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.